-
Asian stock markets fluctuate after mixed tech results
-
Philippine island fights rising seas with nature, not concrete
-
Samsung logs record quarterly profits despite investor AI jitters
-
Bangladesh presses India before Ganges water treaty expires
-
Miami stumble to draw against Cincinnati despite Suarez strike
-
Trump accuses Alaska Democrats of fraud over same-name scandal
-
Bangladesh scrambling as Ganges water treaty to expire
-
Spain mourns after latest train tragedy kills 68
-
England in peril with Rugby League World Cup semi spots at stake
-
Trump's border: quiet, but few people are happy
-
Antonelli ready to rewrite the Formula One record books in Mexico
-
Australian defence chief says China military buildup creating 'pressure' in SE Asia
-
EU, Canada to build 'new chapter' in alliance at Montreal summit
-
No penalty practice? No problem for Man City in shoot-out win
-
Argentine football fan jailed for threats over Di Maria return
-
Microsoft beats expectations fueled by Azure cloud business
-
Liverpool beat Chelsea in League Cup shoot-out, Man City survive scare
-
Chelsea win as Bayern draw with Madrid in Women's Champions League
-
Inter leave it late again in Serie A as AC Milan, Juventus lose
-
Kane watches as Bayern cruise into German Cup last 16
-
Shares in Google owner Alphabet plummet on profit miss, ad slowdown
-
Bayern boss Kompany out of hospital after meningeal irritation
-
Putin hails Elon Musk as 'truly a genius'
-
Shares in Google owner Alphabet sink on profit miss, ad slowdown
-
US stocks eye big tech earnings as Fed holds rates steady
-
Chelsea win as Bayern and Madrid draw in Women's Champions League
-
US Fed holds interest rates steady despite 'too high' inflation
-
Made with munitions from the Falklands War, a 'Chalice of Peace' for the pope
-
Rwanda cannot be blamed for what happens in DR Congo, FM says
-
Pioneering US labor leader Dolores Huerta dies at 96
-
Inter leave it late again in Serie A as Bologna sink AC Milan
-
Italian PM slams 'shameful' release of alleged protest organiser
-
Bolsonaro's escape to the US: How it happened
-
Hollywood producer Kennedy to head LA28 Olympic ceremony plans
-
Russell calls on Scotland to 'kick on' and beat big teams
-
Djokovic wins Basel opener to boost ATP Finals bid
-
Airbus aims for record deliveries despite disappointing quarter
-
US Fed holds interest rates steady despite surging inflation
-
Cuba wins UN vote against US embargo with weakest backing in 30 years
-
Chiefs sign ex-Ravens kicker suspended over sex allegations
-
Real Madrid, La Liga apology over Mbappe shows power of Chinese market
-
Inglis and Carey put Australia in command of South Africa decider
-
From Gaza to Ramallah, Palestinians see little hope in Israeli vote
-
92-year-old US judge handling Maduro case dies
-
US labor leader Dolores Huerta dead: family
-
Perez extends Cadillac deal to 2029
-
Investors turn cautious ahead of tech results, Fed update on rates
-
Arab Israelis proud of high election turnout, uncertain for future
-
'Cruise for life' strands passengers in Cambodia as operator goes bust
-
Inglis, Carey put Australia in command of South Africa decider
AMC Health Appoints Sol Babani and Symbiosis Advisors as Strategic Advisor to Its Decentralized Clinical Trial Service Line
Industry veteran brings deep CRO and biopharma expertise from ICON, PRA Health Sciences, and Covance to accelerate growth and operationalization of AMC Health's DCT platform
NEW YORK CITY, NY / ACCESS Newswire / May 5, 2026 / AMC Health today announced the appointment of Sol Babani, Founder and CEO of Symbiosis Advisors, as Strategic Advisor to its newly established Decentralized Clinical Trial (DCT) service line. Babani will work closely with CEO Nesim Bildirici and Keith Tode, Executive Vice President of Decentralized Clinical Trials, to grow and operationalize AMC Health's DCT platform as it expands its modular operating partner offering to biopharmaceutical sponsors, medical device companies, and CROs.
"As we move into active commercialization of our DCT service line, Sol's depth across the CRO and sponsor landscape is exactly the strategic muscle we need. He's not just advising, he's helping us build the commercial engine."
- Nesim Bildirici, Chief Executive Officer, AMC Health
ABOUT SOL BABANI & SYMBIOSIS ADVISORS
Sol Babani is the Founder of Symbiosis Advisors, a strategic advisory firm serving start-up and mid-market healthcare and life sciences companies. Symbiosis specializes in positioning organizations for growth, preparing them for the scrutiny of transactions, and building strategic partnerships and alliances - embedding directly within client leadership teams to align expertise with vision.
Babani brings decades of senior CRO and biopharma industry experience, having served as Senior Vice President at ICON Biotech, Senior Vice President of Drug Development at PRA Health Sciences, and Vice President of Biopharma Solutions at Covance. His career spans pharma, biotech, and medical device, giving AMC Health access to one of the most experienced commercial and operational minds in the clinical research industry.
"What caught my attention about AMC Health is how few companies in this space have both the clinical infrastructure and the operational maturity to serve as a true operating partner. That combination is rare, and it's exactly what the sponsor and CRO market is looking for right now."
- Sol Babani, Founder, Symbiosis Advisors & Strategic Advisor, AMC Health DCT
A STRATEGIC PARTNERSHIP BUILT FOR GROWTH
The appointment of Babani and Symbiosis Advisors reflects AMC Health's commitment to building its DCT service line with the commercial rigor and strategic infrastructure required to compete at the highest level of the clinical research market. With Babani's network and expertise in CRO and sponsor partnerships, AMC Health is positioned to accelerate the adoption of its modular DCT operating model across the life sciences industry.
ABOUT AMC HEALTH
AMC Health is a remote patient monitoring and decentralized clinical trial services company with a proven track record supporting the U.S. Department of Veterans Affairs. Through its DCT Platform, AMC Health delivers modular operating partner services to biopharmaceutical sponsors, medical device companies, and CROs across fully remote and hybrid clinical study designs. For more information, visit www.amchealth.com.
ABOUT SYMBIOSIS ADVISORS
Symbiosis Advisors is a strategic advisory firm helping start-up and mid-market healthcare and life sciences companies position themselves for success, prepare for transactions, and build top-tier strategic partnerships and alliances. Symbiosis works side by side with client leadership teams, embedding expertise directly within the organization to build stronger, more valuable companies. For more information, visit www.symbiosisadvisors.com.
Contact Information
Gary Feiner
Director of Marketing
[email protected]
(877) 262-2240
SOURCE: AMC Health
View the original press release on ACCESS Newswire
A.Malone--AMWN